Skip to main content

[vc_row][vc_column][vc_single_image image="62971" img_size="full" alignment="center" css=""][vc_column_text css=""]Two NFCR-supported researchers have recently published in the high-impact publication Nature Communications for their work on liquid biopsies and circulating tumor cells. Drs. Daniel A. Haber of Massachusetts General Hospital Cancer Center and Aditya Bardia of the University of California,...

[vc_row][vc_column][vc_single_image image="48401" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] A new test can identify a range of cancers in patients with non-specific symptoms. One of the most troubling things about cancer is the time it can take to reach a diagnosis if the symptoms are not clear-cut. While some cancers...

[vc_row][vc_column][vc_single_image image="25383" img_size="full" alignment="center"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] “It’s what I consider the most interesting science in the world,” says NFCR Fellow Danny Welch, Ph.D. He is alluding to his work discovering the presence of metastasis-suppressing genes in human DNA. Welch, the Hall Family Professor of Molecular Medicine, a professor...